Cost-effectiveness of biologics in early rheumatoid arthritis
Contributeurs/tricesFinckh, Axel; Bansback, Nick; Liang, Matthew H.
Publié dansAnnals of internal medicine, vol. 152, no. 5, p. 333-334;authorreply334
Date de publication2010
Mots-clés
- Antirheumatic Agents/*economics/therapeutic use
- Arthritis, Rheumatoid/*drug therapy
- Cost-Benefit Analysis
- Humans
- Immunologic Factors/*economics/therapeutic use
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
FINCKH, Axel, BANSBACK, Nick, LIANG, Matthew H. Cost-effectiveness of biologics in early rheumatoid arthritis. In: Annals of internal medicine, 2010, vol. 152, n° 5, p. 333–334;authorreply334. doi: 10.1059/0003-4819-152-5-201003020-00018
Identifiants
- PID : unige:20460
- DOI : 10.1059/0003-4819-152-5-201003020-00018
- PMID : 20194244
ISSN du journal0003-4819
